# Topiramate for the Treatment of Methamphetamine Dependence - 1

> **NCT00345371** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 140 (actual)

## Conditions studied

- Methamphetamine

## Interventions

- **DRUG:** Topiramate
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00345371
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-08
- **Final completion:** 2008-12
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345371, "Topiramate for the Treatment of Methamphetamine Dependence - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00345371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*